Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa (SOLSTICE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03584165 |
|
Recruitment Status :
Enrolling by invitation
First Posted : July 12, 2018
Last Update Posted : May 8, 2023
|
Sponsor:
NightstaRx Ltd, a Biogen Company
Information provided by (Responsible Party):
Biogen ( NightstaRx Ltd, a Biogen Company )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Enrolling by invitation |
|---|---|
| Estimated Primary Completion Date : | June 4, 2026 |
| Estimated Study Completion Date : | June 4, 2026 |